Baxter International Inc. (BAX) Company Profile & Statistics

Baxter International Inc.
BAX
(NYSE)
Open
36.79
-0.56 (-1.50%)
in:usd•As of: Oct 03, 2023 13:49 UTC -4
Open
37.29
High
37.30
Low
36.66

About Baxter International Inc.

CEO

Jose E. Almeida

Headquarters

one baxter parkway, df2-1w

deerfield, il 60015, united states

Auditor

PricewaterhouseCoopers LLP

Employees

60,000

Share Holders

20,076

Website

www.baxter.com

Industry

medical specialties

Sector

health technology

Company Overview

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.

Baxter International Inc. Statistics

Valuation Measures

Market Capitalization ²	18.63B
Enterprise Value	33.39B
Enterprise Value/EBITDA (ttm)	14.76
Price to Earnings Ratio (ttm)	13.29
Price to Book (mrq)	3.39
Price to Sales (ttm)	1.27
Price to Cash (ytd)	3.01

Profitability

Gross Margin (ttm)	33.79%
Operating Margin (ttm)	9.57%
Profit Margin (ttm)	-18.99%
Return on Equity (ttm)	24.94%
Return on Invested Capital (ttm)	-13.05%
Return on Assets (ttm)	5.11%

Income Statement

Revenue (ttm)	15.17B
Revenue Per Share (ttm)	29.95
Gross Profit (ttm)	5.14B
EBITDA (ttm)³	2.26B
Net Income Avi to Common (ttm)	-2.85B
Diluted EPS (ttm)	-5.66

Share Statistics

Beta (5Y Monthly)	0.62
52-Week Change	-32.09%
S&P500 52-Week Change	15.02%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	506.40M
Dividend Yield	3.07%
Float ⁴	505.14M
% Held by Insiders	0.25%
% Held by Institutions	85.47%

Balance Sheet

Total Cash (mrq)	1.72B
Total Cash Per Share (mrq)	3.40
Total Debt (mrq)	16.48B
Total Debt/Equity (mrq)	292.72%
Current Ratio (mrq)	1.42%
Quick Ratio (mrq)	0.92%
Book Value Per Share (mrq)	11.12

Cash Flow

Operating Cash Flow Per Share (ytd)	1.64
Free Cash Flow (ytd)	502.00M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Baxter International Inc.

Trade With A Regulated Broker